These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10802271)

  • 21. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects on bone mineral density of low-dosed oral contraceptives compared to and combined with physical activity.
    Hartard M; Bottermann P; Bartenstein P; Jeschke D; Schwaiger M
    Contraception; 1997 Feb; 55(2):87-90. PubMed ID: 9071517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls.
    Cromer BA; Stager M; Bonny A; Lazebnik R; Rome E; Ziegler J; Debanne SM
    J Adolesc Health; 2004 Dec; 35(6):434-41. PubMed ID: 15581522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of triphasic and biphasic oral contraceptive preparations on HDL-cholesterol and LDL-cholesterol in young women.
    Percival-Smith RK; Morrison BJ; Sizto R; Abercrombie B
    Contraception; 1987 Feb; 35(2):179-87. PubMed ID: 3595143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of relationship between hip and spine bone mineral density and oral contraceptive use.
    Murphy S; Khaw KT; Compston JE
    Eur J Clin Invest; 1993 Feb; 23(2):108-11. PubMed ID: 8462619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel.
    Fioretti P; Fruzzetti F; Navalesi R; Ricci C; Miccoli R; Cerri M; Orlandi MC; Melis GB
    Contraception; 1987 Mar; 35(3):229-43. PubMed ID: 2956055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.
    Price TM; Dupuis RE; Carr BR; Stanczyk FZ; Lobo RA; Droegemueller W
    Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral contraception usage in relation to bone mineral density and bone turnover in adolescent girls.
    Lattakova M; Borovsky M; Payer J; Killinger Z
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):207-14. PubMed ID: 19565418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone density in a population of long term oral contraceptive pill users does not differ from that in menstruating women.
    MacDougall J; Davies MC; Overton CE; Gulekli B; Hall M; Bounds W; Jacobs HS; Guillebaud JG
    Br J Fam Plann; 1999 Oct; 25(3):96-100. PubMed ID: 10567058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA; Bonnar J
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study.
    Prior JC; Kirkland SA; Joseph L; Kreiger N; Murray TM; Hanley DA; Adachi JD; Vigna YM; Berger C; Blondeau L; Jackson SA; Tenenhouse A
    CMAJ; 2001 Oct; 165(8):1023-9. PubMed ID: 11699697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of oral contraceptives and cardiovascular disease.
    Chasan-Taber L; Stampfer MJ
    Ann Intern Med; 1998 Mar; 128(6):467-77. PubMed ID: 9499331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.
    Walsh BW; Sacks FM
    J Clin Invest; 1993 May; 91(5):2126-32. PubMed ID: 8486779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiepileptic medication and oral contraceptive interactions: a national survey of neurologists and obstetricians.
    Krauss GL; Brandt J; Campbell M; Plate C; Summerfield M
    Neurology; 1996 Jun; 46(6):1534-9. PubMed ID: 8649543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of oral contraceptive different patterns of use on circulating IGF-1 and bone mineral density in healthy premenopausal women.
    Elkazaz AY; Salama K
    Endocrine; 2015 Feb; 48(1):272-8. PubMed ID: 24861474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.
    Wild RA; Demers LM; Applebaum-Bowden D; Lenker R
    Contraception; 1991 Aug; 44(2):113-24. PubMed ID: 1893706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of low-dose oral contraceptives on androgenic markers and acne.
    Thorneycroft IH; Stanczyk FZ; Bradshaw KD; Ballagh SA; Nichols M; Weber ME
    Contraception; 1999 Nov; 60(5):255-62. PubMed ID: 10717776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral contraception: current use and attitudes.
    Jones KP
    Contraception; 1999 Jan; 59(1 Suppl):17S-20S. PubMed ID: 10342091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
    Wiegratz I; Jung-Hoffmann C; Gross W; Kuhl H
    Contraception; 1998 Aug; 58(2):83-91. PubMed ID: 9773262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.